Recently, AGPS overexpression was associated with cancer cell aggressiveness and invasiveness in primary breast tumors and cancer cell lines (breast (231MFP), melanoma (C8161), and prostate (PC3) cancer cells) [45]. Here, AGPS is linked to cancer.